Paper40246790
A Systematic Review of Pharmacokinetic Studies of Colistin and Polymyxin B in Adult Populations.
Zamri PJ and 4 others. Clin Pharmacokinet, 2025. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. A Systematic Review of Pharmacokinetic Studies of Colistin and Polymyxin B in Adult Populations. Papers, record 40246790. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40246790
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Systematic Review of Pharmacokinetic Studies of Colistin and Polymyxin B in Adult Populations.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colistin | Major topic |
| Polymyxin B | Major topic |
| Anti-Bacterial Agents | Major topic |
| Humans | |
| Critical Illness | |
| Adult |
Source PubMed
References88
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27799209 | Dosing and Pharmacokinetics of Polymyxin B in Patients with Renal Insufficiency. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/27799209 | PubMed |
| 2 | 35716048 | The population pharmacokinetics and dose optimization of polymyxin B in critically ill patients with or without extracorporeal membrane oxygenation. | J Clin Pharm Ther | 2022 | https://conductscience.org/library/papers/35716048 | PubMed |
| 3 | 30710469 | International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). | Pharmacotherapy | 2019 | https://conductscience.org/library/papers/30710469 | PubMed |
| 4 | 36375775 | Pharmacokinetics and pharmacodynamics of polymyxin B and proposed dosing regimens in elderly patients with multi-drug-resistant Gram-negative bacterial infections. | Int J Antimicrob Agents | 2022 | https://conductscience.org/library/papers/36375775 | PubMed |
| 5 | 23508665 | Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection. | Eur J Clin Pharmacol | 2013 | https://conductscience.org/library/papers/23508665 | PubMed |
| 6 | 35609779 | Population pharmacokinetics of polymyxin B and dosage strategy in critically ill patients with/without continuous renal replacement therapy. | Eur J Pharm Sci | 2022 | https://conductscience.org/library/papers/35609779 | PubMed |
| 7 | 37461291 | Population pharmacokinetics of polymyxin B in patients with liver dysfunction. | Br J Clin Pharmacol | 2023 | https://conductscience.org/library/papers/37461291 | PubMed |
| 8 | 35722356 | Plasma concentrations of Colistin sulfate in a patient with septic shock on extracorporeal membrane oxygenation and continuous renal replacement therapy: a case report. | Ann Transl Med | 2022 | https://conductscience.org/library/papers/35722356 | PubMed |
| 9 | 23147733 | Colistin methanesulfonate and colistin pharmacokinetics in critically ill patients receiving continuous venovenous hemodiafiltration. | Antimicrob Agents Chemother | 2013 | https://conductscience.org/library/papers/23147733 | PubMed |
| 10 | 28011614 | Dosing guidance for intravenous colistin in critically-ill patients. | Clin Infect Dis | 2017 | https://conductscience.org/library/papers/28011614 | PubMed |
| 11 | 21555763 | Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. | Antimicrob Agents Chemother | 2011 | https://conductscience.org/library/papers/21555763 | PubMed |
| 12 | 36588676 | Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36588676 | PubMed |
| 13 | 27793510 | Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet? | Int J Antimicrob Agents | 2016 | https://conductscience.org/library/papers/27793510 | PubMed |
| 14 | 23179561 | Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis. | J Antimicrob Chemother | 2013 | https://conductscience.org/library/papers/23179561 | PubMed |
| 15 | 36702748 | Population pharmacokinetics and limited sampling strategies of polymyxin B in critically ill patients. | J Antimicrob Chemother | 2023 | https://conductscience.org/library/papers/36702748 | PubMed |
| 16 | 28893780 | Pharmacokinetic/Toxicodynamic Analysis of Colistin-Associated Acute Kidney Injury in Critically Ill Patients. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/28893780 | PubMed |
| 17 | 29998877 | Pharmacokinetics of colistin in patients with multidrug-resistant Gram-negative infections: A pilot study. | Indian J Med Res | 2018 | https://conductscience.org/library/papers/29998877 | PubMed |
| 18 | 32052041 | Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing Position Statements on Polymyxin B and Colistin Clinical Breakpoints. | Clin Infect Dis | 2020 | https://conductscience.org/library/papers/32052041 | PubMed |
| 19 | 26369974 | Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/26369974 | PubMed |
| 20 | 20558557 | Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration. | Chest | 2010 | https://conductscience.org/library/papers/20558557 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943519 | Distribution and Antimicrobial Resistance Patterns of Critical and High-Priority Gram-Negative Pathogens Isolated from Endotracheal Aspirates in an Intensive Care Unit. | Microorganisms | 2026 | https://conductscience.org/library/papers/42943519 | PubMed |
| 42745804 | Physiologically-based pharmacokinetic model to predict loading dose polymyxin B exposure in critically ill patients with sepsis. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42745804 | PubMed |
| 42712890 | A population pharmacokinetic model library for polymyxin B: clinical implementation of model-informed precision dosing. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42712890 | PubMed |
| 42695405 | Targeting integrated cell death networks in sepsis‑associated acute kidney injury: Shared regulatory nodes and diet‑related small molecule modulation (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42695405 | PubMed |
| 42645583 | Antimicrobial Peptides as Eco-Innovative Therapeutics to Overcome Antifungal Pressure-Induced Resistance in Candida Infections. | Curr Microbiol | 2026 | https://conductscience.org/library/papers/42645583 | PubMed |
| 42572787 | Comparative Effectiveness of Colistin Sodium versus Polymyxin B Sulfate Against CR-GNB: A Retrospective Cohort Study. | Infect Drug Resist | 2026 | https://conductscience.org/library/papers/42572787 | PubMed |
| 42490869 | Pharmacokinetics of polymyxin drugs in special populations. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42490869 | PubMed |
| 42422069 | Can the two-point method based on peak and trough concentrations accurately estimate the area under the curve of polymyxin B? A Monte Carlo simulation study. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42422069 | PubMed |
| 42356498 | Immunoassay for Colistin Monitoring in Critically Ill Patients Receiving Colistin Methanesulfonate Therapy. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42356498 | PubMed |
| 42325914 | Optimizing Colistin Sulfate Dosing in Severe Infections: A Population Pharmacokinetic Model-Guided Approach. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42325914 | PubMed |
| 42321962 | Polymyxin B Intravenous Administration Strategy Guided by Minimum Inhibitory Concentration in Critically Ill Patients With Pulmonary Infection: Insights From PBPK Modeling. | CPT Pharmacometrics Syst Pharmacol | 2026 | https://conductscience.org/library/papers/42321962 | PubMed |
| 42246008 | Predictors of clinical outcomes in Chinese patients with carbapenem-resistant Gram-negative bacterial infections receiving colistimethate sodium: a retrospective cohort study. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42246008 | PubMed |
| 42243196 | Clinician decision-making for polymyxin dosing in critically ill patients with renal impairment: a qualitative study. | Sci Rep | 2026 | https://conductscience.org/library/papers/42243196 | PubMed |
| 42183845 | Synergistic strategies to rescue the last-resort antibiotic colistin. | Arch Microbiol | 2026 | https://conductscience.org/library/papers/42183845 | PubMed |
| 41868176 | Therapeutic Monitoring of Polymyxin B in Critically Ill Patients with Carbapenem-Resistant Organisms: Evaluation Based on Steady-State Trough and Peak Concentrations. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/41868176 | PubMed |
| 41779724 | Clinical outcomes with lower versus conventional dose polymyxin B regimens in dialysis dependent and non-dialysis patients with gram-negative sepsis: A real-world propensity-score matched cohort study. | PLoS One | 2026 | https://conductscience.org/library/papers/41779724 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40246790
GET https://conductscience.org/api/papers/v1/40246790/references?page=2